Drug resistance patterns in pulmonary tuberculosis

Journal of the Pakistan Medical Association

Volumn 61, Issue 3, 2011, Pages 229-232

  Khoharo, Haji Khan ^a   Shaikh, Imran Ali ^b  

^a Muhammad Medical College & Hospital   (Pakistan)

^b LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES   (Pakistan)

Author keywords

Drug resistant tuberculosis; MDR TB; Multidrug resistance

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CULTURE MEDIUM; FEMALE; HUMAN; INOCULATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PAKISTAN; PROSPECTIVE STUDY; SPUTUM ANALYSIS; STAINING;

ADULT; AGE DISTRIBUTION; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; PROSPECTIVE STUDIES; SEX DISTRIBUTION; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 79952212103     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report 2008 Geneva 27, Switzerland.
2. Patel D, Madan I. Methicillin resistant Staphylococcus aureus and multi drug resistant tuberculosis: Part 2.Occup Med (Lond) 2000; 50: 395-7.
3. Rajabhandary SS, Marks SM, Bock NN. Costs of patients hospitalized for multi-drug resistant tuberculosis. Int J Tuberc Lung Dis 2004; 8: 1012-6.
4. Gupta R, Kim JY, Espinal MA, Caudran JM, Pecoul B, Farmer PE, et al. Responding to market failure in tuberculosis control. Science 2001; 293: 1049-50.
5. Dye C, Espinal Ma, Watt CJ Mbiaga C, Williams BG. Worldwide incidence of multi-drug resistant tuberculosis. J Infect Dis 2002; 185: 1197-203.
6. Nettlemon MD. Multi-drug resistant tuberculosis: new from the front. JAMA 2005; 293: 2788-90.
7. World Health Organization. Antituberculosis Drug Resistance in the World, Report Number 3. Geneva, Switzerland: World Health Organization; 2005.
8. Gillespie SH. Evolution of drug resistance in Mycobacterium tuberculosis: Clinical and Antimicrob Agents Chamother 2002; 46: 267-74.
9. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Sooligen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843-9.
10. Munsiff SS, Nivin B, Sacajiu G, Mathema B, Pirani P, Kreiswirth BN. Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999. J Infect Dis 2003; 188: 356-63.
11. Ikram A, Ali S, Ali W, Wiqar AM. Latest pattern of multi-drug resistant tuberculosis in Pakistan. Inf Dis J Pak Science 2008; 17: 14-7.
12. World Health Organization. Treatment of tuberculosis guidelines for national programmes. WHO report 2008 Geneva 27, Switzerland.
13. Balows A., Hausler W J Jr, Herrmann, KL., Isenberg, HD, Shadomy, H J (editors). Manual of Clinical Microbiology, 5th ed. Washington, DC: American Society for Microbiology, 1991; pp 356-9.
14. Dam T, Isa M, Bose M. Drug sensitivity profile of clinical mycobacterium tuberculosis isolates - a retrospective study from a chest disease institute of India. J Med Microbiol, 2005; 54: 269-71.
15. Heifets LB. Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. CRC Press, Boca Raton, FL, USA, 1991; 178-89.
16. Richter E, Rusch-Gerdes S, Hillemann D. Drug susceptibility testing in TB: Current status and future prospects. Expert Rev Resp Med 2009; 3: 497-510.
17. Butt T, Ahmad R N, Kazmi S Y, Rafi N. Multi-drug resistant tuberculosis in Pakistan. J Pak Med Assoc 2004; 54: 469-72.
18. Irfan S, Hassan Q, Hasan R. Assessment of resistance in Multi-Drug Resistant Tuberculosis patients. J Pak Med Assoc 2006; 56: 397-400.
19. Karamat KA, Rafi S, Abbasi S. Drug resistance in mycobacterium tuberculosis: a four years experience. J Pak Med Assoc 1999; 49: 262-5.
20. Shaikh MA, Khokhar NA, Maheshwari N, Qazi I. Prevalence of drug resistance in pulmonary Tuberculosis. J Liaquat Uni Med Health Sci 2008; 07: 79-82.
21. Rahman M, Kamal SMS, Mohammed FR, Alam MB, Ahasan HN. Antituberculosis drug resistance pattern among different category of tuberculosis patients. J Medicine 2009; 10: 45-7.
22. Khoharo HK, Ansari S, Qureshi F. Rising menace of multidrug resistant mycobacteria in pulmonary tuberculosis. J Liaquat Uni Med Health Sci 2009; 8: 96-9.
23. Almeida D, Rodrigues C, Udwadia ZF, Lalvani A, Gothi GD, Mehta P, et al. Incidence of Multidrug-Resistant Tuberculosis in urban and rural India and implications for prevention. Clin Infect Dis 2003; 36: e152-4.
24. Akhter S, Haidri FR, Memon AM. Drug resistance to tuberculosis in a tertiary care settting in Karachi. J Pak Med Assoc 2007: 57: 282-4.
25. Rao NA, Irfan M, Hussain SJ. Primary drug resistance against Mycobacterium tuberculosis in Karachi. J Pak Med Assoc 2008; 58: 122-5.